SCCNP - Overview: Severe Congenital and Cyclic Neutropenia Gene Panel, Varies

Providing a genetic evaluation for patients with a personal or family history suggestive of severe congenital neutropenia and/or cyclic neutropenia Establishing a diagnosis of an inherited congenital neutropenia and, in some cases,...

BUPS - Overview: Buprenorphine Screen, Random, Urine

Screening for drug abuse or use of buprenorphine

AMPHU - Overview: Amphetamines Confirmation, Random, Urine

Confirming drug exposure involving amphetamines such as amphetamine and methamphetamine, phentermine, pseudoephedrine/ephedrine, methylenedioxyamphetamine (MDA), and methylenedioxymethamphetamine (MDMA)

ALPI - Overview: Alkaline Phosphatase Isoenzymes, Serum

Aid in the diagnosis and treatment of liver, bone, intestinal, and parathyroid diseases Determining the tissue source of increased alkaline phosphatase (ALP) activity in serum Differentiating between liver and bone sources of elevated...

VITC - Overview: Ascorbic Acid (Vitamin C), Plasma

Identifying vitamin C deficiency

AHPRU - Overview: Antihypertension Panel, Random, Urine

Aid in the management of hypertension, especially treatment resistant hypertension Monitoring compliance in individuals prescribed antihypertensive drug therapy As a screen for to detect nonprescribed use of common diuretics

AMTRP - Overview: Amitriptyline and Nortriptyline, Serum

Monitoring amitriptyline and nortriptyline serum concentrations during therapy Evaluating potential amitriptyline and nortriptyline toxicity May aid in evaluating patient compliance

AACYL - Overview: Aminoacylase-1 Deficiency, Urine

Follow-up quantitation of abnormal organic acid elevations of N-acetylated amino acids, in particular N-acetylalanine, N-acetylglycine, N-acetylmethionine, and N-acetylglutamic acid Diagnosis of individuals with aminoacylase-1...

AMPHM - Overview: Amphetamine-Type Stimulants Confirmation, Meconium

Detecting in utero exposure to amphetamine-type stimulants up to 5 months before birth

ASB - Overview: Arsenic, Blood

Detecting acute or very recent arsenic exposure Monitoring the effectiveness of therapy This test is not useful for evaluation of chronic arsenic exposure.

CDOU - Overview: Cadmium Occupational Exposure, Random, Urine

Detecting occupational exposure to cadmium using random urine specimens

ETGS - Overview: Ethyl Glucuronide Screen, Random, Urine

Screening for drug abuse involving alcohol

THCCU - Overview: Delta-9-Carboxy-Tetrahydrocannabinol Confirmation and Creatinine Ratio, Random, Urine

Measuring the delta-9 carboxy-tetrahydrocannabinol to creatinine ratio as a part of a profile

CURCU - Overview: Copper/Creatinine Ratio, Random, Urine

Investigation of Wilson disease and obstructive liver disease using a random urine specimen

PDSUX - Overview: Drug Screen, Prescription/Over the Counter, Chain of Custody, Random, Urine

Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent Providing, when possible, the identification of all drugs in the specimen This test is...

DSS - Overview: Drug Screen, Prescription/Over the Counter, Serum

Detection and identification of prescription or over the counter drugs frequently found in drug overdose or used with a suicidal intent Qualitatively identifying drugs present in the specimen; quantification of identified drugs, when...

EEPC - Overview: Eastern Equine Encephalitis Antibody Panel, IgG and IgM, Spinal Fluid

Aiding in the diagnosis of Eastern equine encephalitis using spinal fluid specimens

CLOM - Overview: Clomipramine, Serum

Determining whether a poor therapeutic response is attributable to noncompliance Monitoring serum concentration of clomipramine and norclomipramine to assist in optimizing the administered dose

COKEM - Overview: Cocaine and Metabolites Confirmation, Meconium

Detecting in utero drug exposure up to 5 months before birth

CAVPC - Overview: California Virus (La Crosse) Encephalitis Antibody Panel, IgG and IgM, Spinal Fluid

Aiding in the diagnosis of California (La Crosse) encephalitis using spinal fluid specimens

ALCX - Overview: Ethanol, Chain of Custody, Blood

Detection of ethanol (ethyl alcohol) in blood to document prior consumption or administration of ethanol Quantification of the concentration of ethanol in blood correlates directly with degree of intoxication All testing is performed...

CYSPR - Overview: Cyclosporine, Blood

Monitoring whole blood cyclosporine concentration during therapy, particularly in individuals coadministered cytochrome P450 (CYP) 3A4 substrates, inhibitors, or inducers Adjusting dose to optimize immunosuppression while minimizing...

BUPM - Overview: Buprenorphine and Norbuprenorphine, Random, Urine

Monitoring of compliance utilizing buprenorphine Detection and confirmation of the illicit use of buprenorphine

B2MC - Overview: Beta-2-Microglobulin (Beta-2-M), Spinal Fluid

Evaluation of central nervous system inflammation and B-cell proliferative diseases

CRWB - Overview: Chromium, Blood

Monitoring exposure to chromium using whole blood specimens Monitoring metallic prosthetic implant wear

BARBX - Overview: Barbiturates Confirmation, Chain of Custody, Random, Urine

Detecting drug abuse involving barbiturates such as amobarbital, butalbital, pentobarbital, phenobarbital, and secobarbital Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to...

CYCPK - Overview: Cyclosporine, Peak, Blood

Monitoring whole blood peak cyclosporine concentration during therapy, particularly in individuals coadministered cytochrome P450 (CYP) 3A4 substrates, inhibitors, or inducers Adjusting dose to optimize immunosuppression while minimizing...

CARNP - Overview: Carbapenemase Detection-Carba NP Test, Varies

Confirming carbapenemase production from pure isolates of Enterobacterales or Pseudomonas aeruginosa

CDCU - Overview: Cadmium/Creatinine Ratio, Urine

Detecting exposure to cadmium using random urine specimens

LDPU - Overview: Limited Drug Profile, 3 Drug Classes, Immunoassay, Random, Urine

Detecting drug use involving barbiturates, cocaine, and carboxy-tetrahydrocannabinol This test is not intended for use in employment-related testing.

PBUOE - Overview: Lead Occupational Exposure, Random, Urine

Detecting clinically significant lead exposure due to occupational exposure This test is not a substitute for blood lead screening.

HALO - Overview: Haloperidol, Serum

Optimizing haloperidol dosage Monitoring patient compliance Assessing toxicity

KINET - Overview: Ki-67(MIB-1), Gastrointestinal/Pancreatic Neuroendocrine Tumors, Quantitative Immunohistochemistry, Automated

Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with neuroendocrine tumors of the pancreas or gastrointestinal tract including metastases

HGUOE - Overview: Mercury Occupational Exposure, Random, Urine

Detecting mercury toxicity due to occupational exposure

MET - Overview: Methemoglobin and Sulfhemoglobin, Blood

Diagnosing methemoglobinemia and sulfhemoglobinemia Identifying cyanosis due to other causes, such as congenital heart disease

MNU - Overview: Manganese, 24 Hour, Urine

Monitoring manganese exposure using 24 hour urine collections Nutritional monitoring

PBCU - Overview: Lead/Creatinine Ratio, Urine

Detecting clinically significant lead exposure using random urine specimens This test is not a substitute for blood lead screening.

KI67P - Overview: Ki-67(MIB-1), Pulmonary, Quantitative Immunohistochemistry, Automated

Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with carcinoid or atypical carcinoid of the lung including metastases

THCG - Overview: Human Chorionic Gonadotropin (hCG), Quantitative, Pregnancy, Serum

Early detection of pregnancy Investigation of suspected ectopic pregnancy or other pregnancy-related complications Monitoring in vitro fertilization patients This test is not useful for detecting or monitoring tumors or gestational...

HMNA - Overview: Heavy Metals, Nails

Detection of nonacute arsenic, mercury, and lead exposure

IMIPR - Overview: Imipramine and Desipramine, Serum

Monitoring imipramine and desipramine concentrations during therapy Evaluating potential imipramine and desipramine toxicity May aid in evaluating patient compliance

IRON - Overview: Iron, Serum

Aiding in the evaluation of iron deficiency and iron overload diseases in combination with total iron binding capacity and percent saturation Assessment of acute iron poisoning

HYPOG - Overview: Hypoglycemic Agent Screen, Serum

Evaluation of suspected insulinoma characterized by hypoglycemia and increased serum insulin concentration Detecting drugs that stimulate insulin secretion Drugs detected by this procedure are: -The first-generation sulfonylureas:...

LAMO - Overview: Lamotrigine, Serum

Monitoring serum concentration of lamotrigine Assessing compliance Adjusting lamotrigine dose in patients receiving other anticonvulsant drugs that interact pharmacokinetically with lamotrigine

FENTS - Overview: Fentanyl, Serum

Monitoring fentanyl therapy

FENTU - Overview: Fentanyl with Metabolite Confirmation, Random, Urine

Detection and confirmation of illicit drug use involving fentanyl

LGBWB - Overview: Globotriaosylsphingosine, Blood

Screening of patients with Fabry disease when a serum specimen is not available This test should not be used for newborn screening followup.

FENR - Overview: Fentanyl Screen with Reflex, Random, Urine

Screening for drug abuse or use involving fentanyl and confirmation of fentanyl if present in the screen

MYGLU - Overview: Myoglobin, Random, Urine

Confirming the presence of a myopathy

NCSRY - Overview: Nicotine Survey, Serum

Monitoring tobacco use in a health fair setting